A separate study (using a separate C-terminus targeting monoclonal antibody) detected ROR1 protein at low levels in 15% of pancreatic adenocarcinoma samples (n = 38) [26]. This evidence concerns the gene ROR1 and pancreatic adenocarcinoma.